ストックスクリーナーアプリを入手
441.59
2.14%
9.25
アフターアワーズ：
441.59
前日終値:
$432.34
開ける：
$434.44
24時間の取引高:
218.77K
Relative Volume:
0.87
時価総額：
$5.86B
収益：
$2.54B
当期純損益:
$259.78M
株価収益率:
24.07
EPS:
18.3497
ネットキャッシュフロー:
$377.12M
1週間 パフォーマンス:
+3.56%
1か月 パフォーマンス:
+3.28%
6か月 パフォーマンス:
+4.65%
1年 パフォーマンス:
-21.25%
1日の値動き範囲:
$427.65
$443.16
1週間の範囲:
$415.60
$443.16
52週間の値動き範囲:
$365.20
$565.66
Chemed Corp Stock (CHE) Company Profile
Compare CHE vs HCA, THC, DVA, FMS, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
441.59 | 5.74B | 2.54B | 259.78M | 377.12M | 18.35 |
HCA
Hca Healthcare Inc
|
372.13 | 80.27B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
162.06 | 13.90B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
192.16 | 12.33B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
22.03 | 11.78B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
104.01 | 9.90B | 6.07B | 793.80M | 464.40M | 5.9914 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-27 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | ダウングレード | Jefferies | Buy → Hold |
| 2025-09-02 | アップグレード | Jefferies | Hold → Buy |
| 2025-07-25 | 開始されました | Jefferies | Hold |
| 2020-03-11 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-01 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-06 | 繰り返されました | BofA/Merrill | Buy |
| 2018-10-12 | 開始されました | BofA/Merrill | Buy |
| 2017-08-28 | 開始されました | KeyBanc Capital Mkts | Sector Weight |
| 2016-11-01 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2016-07-27 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2016-05-02 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2015-10-26 | 繰り返されました | Oppenheimer | Outperform |
| 2015-10-26 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2015-09-22 | 繰り返されました | Oppenheimer | Outperform |
| 2015-07-27 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2015-02-19 | 繰り返されました | Oppenheimer | Outperform |
| 2014-09-23 | 繰り返されました | Oppenheimer | Outperform |
| 2014-06-10 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2014-05-01 | 繰り返されました | Oppenheimer | Outperform |
| 2013-09-10 | 繰り返されました | Deutsche Bank | Hold |
| 2011-03-04 | 繰り返されました | Barclays Capital | Underweight |
| 2011-02-17 | 繰り返されました | Oppenheimer | Outperform |
| 2011-02-17 | 繰り返されました | RBC Capital Mkts | Sector Perform |
すべてを表示
Chemed Corp (CHE) 最新ニュース
ETFs Investing in Chemed Corporation Stocks - TradingView
TD Asset Management Inc Has $138.86 Million Stock Holdings in Chemed Corporation $CHE - MarketBeat
Activist Barington targets healthcare firm Chemed - MSN
Activist Barington Targets Healthcare Firm Chemed - Bloomberg.com
CHE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
How (CHE) Movements Inform Risk Allocation Models - Stock Traders Daily
Chemed Corp (CHE) Stock Analysis: Evaluating a Healthcare Giant with a Potential 4.71% Upside - DirectorsTalk Interviews
CHE Technical Analysis & Stock Price Forecast - Intellectia AI
Chemed director Walsh sells $218,915 in stock By Investing.com - Investing.com Canada
Chemed Corp (CHE) Shares Fall 3.1% -- What GF Score of 78 Tells Investors - GuruFocus
Chemed director Walsh sells $218,915 in stock - Investing.com
Chemed (NYSE: CHE) director sells 500 shares in open-market trade - Stock Titan
CHE News | CHEMED CORP (NYSE:CHE) - ChartMill
CHE Q1 2026 Earnings: EPS Beats Estimates by 5.5%Pre-Earnings Drift - thelegaladvocate.com
Chemed Corp (CHE) Edges Higher Amid Steady Trading: Key Levels to WatchMA Crossover - thelegaladvocate.com
Chemed Corp (CHE) Q1 2026 Earnings: EPS Beats Expectations Amid Strong Operational PerformanceRevenue Surprise History - thelegaladvocate.com
Chemed Corp (CHE) Holds Steady Near Support Amid Narrow Trading RangeSupply Zone - thelegaladvocate.com
Chemed Corp (CHE) Stock Report: Navigating Valuation with a 25.60% ROE and a Modest Upside - DirectorsTalk Interviews
Trading Systems Reacting to (CHE) Volatility - Stock Traders Daily
Chemed Corporation 8-K SEC Filing Summary for May 18, 2026 – Key Entity Information and Voting Results - Minichart
Chemed stockholders elect board, ratify auditor, reject executive pay plan - Investing.com
Shareholders at Chemed (NYSE: CHE) vote down pay plan but back board - Stock Titan
Chemed (NYSE: CHE) director awarded 386 shares of company stock - Stock Titan
Chemed (NYSE: CHE) director granted 386 capital shares in stock award - Stock Titan
CHEMED CORP (CHE) director receives 386-share equity award at $440.77 value - Stock Titan
Chemed (NYSE: CHE) director receives stock award, boosting holdings to 5,925 shares - Stock Titan
Director at Chemed (NYSE: CHE) receives 386-share stock award - Stock Titan
CHEMED (NYSE: CHE) director Ron DeLyons granted 386 shares of stock - Stock Titan
Chemed Corporation Stockholders Elect Directors, Ratify Accountants, and Declare Quarterly Dividend - Quiver Quantitative
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend - GlobeNewswire
220 consecutive dividends from the company behind VITAS and Roto-Rooter - Stock Titan
Chemed Corp (CHE) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential with a 2.75% Upside - DirectorsTalk Interviews
Chemed Conference Webcast Puts Dual Businesses And Valuation In Focus - Yahoo Finance
Chemed Corp stock (US1638321034): hospice and plumbing specialist draws investor focus after latest - AD HOC NEWS
TradingKey - TradingKey
Chemed Corp stock (US1638321034): Presentation at RBC Healthcare Conference - AD HOC NEWS
Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference - Caledonian Record
Chemed Corp (CHE) Stock Analysis: Navigating the Healthcare Sector with a 5.24% Potential Upside - DirectorsTalk Interviews
C WorldWide Group Holding A S Invests $2.19 Million in Chemed Corporation $CHE - MarketBeat
How Chemed Corp (CHE) Affects Rotational Strategy Timing - Stock Traders Daily
CHE SEC FilingsChemed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
[144] CHEMED CORP SEC Filing - Stock Titan
Chemed director Patrick P. Grace sells $25,546 in stock By Investing.com - Investing.com Australia
Chemed director Patrick P. Grace sells $25,546 in stock - Investing.com
Chemed Corp (CHE) director sells 60 shares at $425.78 - Stock Titan
Chemed Corp stock (US1638321034): Home health and hospice growth continues to drive earnings - AD HOC NEWS
CHE Stock Price, Quote & Chart | CHEMED CORP (NYSE:CHE) - ChartMill
Chemed Corporation $CHE Shares Acquired by UBS Group AG - MarketBeat
Sadness This Mother's Day? VITAS® Healthcare Launches Free, Nationwide Mother's Day Grief Helpline - Quantisnow
The company behind VITAS and Roto-Rooter presents in Las Vegas May 12 - Stock Titan
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026 - GlobeNewswire
Chemed Corp (CHE) 財務データ
収益
当期純利益
現金流量
EPS
1.23%
1.61%
大文字化:
|
ボリューム (24 時間):